Thermo Fisher Scientifics Amplitude Solution Receives Fda Authorization For Covid-19 Testing

Thermo Fisher Scientifics Amplitude Solution Receives Fda Authorization For Covid-19 Testing

By, Admin 26 April 2021

Thermo Fisher Scientific, The World Leader In Serving Science, Received Emergency Use Authorization (Eua) From The Us Food And Drug Administration (Fda) For Thermo Fisher Scientific Amplitude Solution With The Taqpath Covid-19 High-Throughput Combo Kit.The Modular Solution Processes Samples In A Four-Step Process Requiring Minimum Hands-On Time, Laboratory Space And Staffing Resources. It Was Introduced As An Automated Real-Time Pcr Test That Can Analyze Up To 8,000 Covid-19 Samples In A Single Day. It Empowers Clinical And Public Healthcare Laboratories To Scale Gold Standard Pcr Testing With Minimal Staffing Needs And A Secured Supply Of Kits, Reagents And Consumables To Meet The Rising Testing Demands."India Is Experiencing A More Intense Second Wave Of Covid-19. This Has Compelled The Country To Take Rigorous Measures Of Ramping Up Testing Capacity And Adopt A Nationwide Testing Regime. While A Lab-Based Pcr Test Is The Most Suitable Technology In Terms Of Reliability, Quick Turnaround Time And Scalability, It Still Lacks The Adequate Testing Volume To Satisfy The Status Quo. With The Approval Of Amplitude Solution, Thermo Fisher Can Help To Quickly Double Or Even Triple The Country'S Testing Capacity&Rdquo;, Said Amit Chopra, Managing Director, India And South Asia, Thermo Fisher Scientific.The Amplitude Solution Uses Thermo Fisher'S Applied Biosystems Taqpath Covid-19 Combo Kit, A Quick, Highly Sensitive Multiplex Diagnostic Test That Contains The Assays And Controls Needed For The Qualitative Detection Of Nucleic Acid From Sars-Cov-2, The Virus Responsible For Causing Covid-19. The Kit'S Multi-Gene Target Design And Updated Interpretive Software May Help Labs Detect Sars-Cov-2 Variants."With The Onset Of Vaccination, There Continues To Be Demand For Frequent Routine Testing To Control The Outbreak. While Each State Conducts Testing On Different Capacities, A New Approach For Scaling The Testing Volume Is Essential To Safeguard Human Life. Our High-Yielding, Automated Solution Can Help Laboratories Quickly Scale Covid-19 Testing To Volumes Needed To Help Reduce The Spread Of Disease And Restore Economies And Communities,&Rdquo; Kapil Sood, Senior Director, Life Sciences Solutions, Thermo Fisher Scientific.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!